AbL Diagnostics Market Capitalization vs. Shares Outstanding

ABLD Stock   2.40  0.00  0.00%   
Based on AbL Diagnostics' profitability indicators, AbL Diagnostics SA may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess AbL Diagnostics' ability to earn profits and add value for shareholders.
For AbL Diagnostics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AbL Diagnostics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AbL Diagnostics SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AbL Diagnostics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AbL Diagnostics SA over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between AbL Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AbL Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbL Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AbL Diagnostics SA Shares Outstanding vs. Market Capitalization Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining AbL Diagnostics's current stock value. Our valuation model uses many indicators to compare AbL Diagnostics value to that of its competitors to determine the firm's financial worth.
AbL Diagnostics SA is number one stock in market capitalization category among its peers. It also is number one stock in shares outstanding category among its peers creating about  0.08  of Shares Outstanding per Market Capitalization. The ratio of Market Capitalization to Shares Outstanding for AbL Diagnostics SA is roughly  11.84 . Comparative valuation analysis is a catch-all model that can be used if you cannot value AbL Diagnostics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AbL Diagnostics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

AbL Market Capitalization vs. Competition

AbL Diagnostics SA is number one stock in market capitalization category among its peers. Market capitalization of Railroads industry is presently estimated at about 2.14 Billion. AbL Diagnostics claims roughly 23.76 Million in market capitalization contributing just under 2% to equities listed under Railroads industry.
Capitalization  Workforce  Revenue  Valuation  Total debt

AbL Shares Outstanding vs. Market Capitalization

Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

AbL Diagnostics

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
23.76 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

AbL Diagnostics

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
2.01 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

AbL Shares Outstanding Comparison

AbL Diagnostics is currently under evaluation in shares outstanding category among its peers.

AbL Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on AbL Diagnostics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AbL Diagnostics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AbL Diagnostics' important profitability drivers and their relationship over time.

Use AbL Diagnostics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbL Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbL Diagnostics will appreciate offsetting losses from the drop in the long position's value.

AbL Diagnostics Pair Trading

AbL Diagnostics SA Pair Trading Analysis

The ability to find closely correlated positions to AbL Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbL Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbL Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbL Diagnostics SA to buy it.
The correlation of AbL Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbL Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbL Diagnostics SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbL Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your AbL Diagnostics position

In addition to having AbL Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cannabis Thematic Idea Now

Cannabis
Cannabis Theme
Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally. The Cannabis theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cannabis Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in AbL Stock

To fully project AbL Diagnostics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of AbL Diagnostics SA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include AbL Diagnostics' income statement, its balance sheet, and the statement of cash flows.
Potential AbL Diagnostics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although AbL Diagnostics investors may work on each financial statement separately, they are all related. The changes in AbL Diagnostics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AbL Diagnostics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.